Real-World Studies
Predictors of Trifecta and Pentafecta Achievement in Robot-Assisted Partial Nephrectomy
Ishihara et alInternational Journal of Urology

In a retrospective cohort study evaluating 396 consecutive patients undergoing robot-assisted laparoscopic partial nephrectomy (RAPN) for highly complex cT1N0M0 renal masses (defined by a RENAL nephrectomy score ≥ 10), researchers evaluated determinants of optimal surgical, oncologic, and functional outcomes.
Trifecta success—defined as negative surgical margins, warm ischemia time ≤ 25 minutes, and the absence of surgical complications—was accomplished in 201 patients (51%). On multivariable analysis, independent factors significantly associated with trifecta achievement included right-sided tumors (p = 0.0217), non-hilar tumor location (p = 0.0056), shorter operative duration (p < 0.0001), and an unexposed urinary collecting system (p = 0.0022).
Among 334 patients with complete 1-year functional follow-up, pentafecta criteria—requiring trifecta achievement alongside ≥ 90% preservation of estimated glomerular filtration rate and no chronic kidney disease stage upgrading at 12 months—were met by 104 patients (31%). After adjusting for covariates, independent predictors for pentafecta achievement were non-hilar tumor location (p = 0.0449), shorter operative time (p = 0.0003), and an unexposed urinary collecting system (p = 0.0004). These anatomical and operative variables provide objective metrics for risk stratification and surgical outcome prediction when planning RAPN in patients with highly complex renal tumors.
Key Takeaways
- Trifecta was achieved in 51% (201/396) of patients undergoing RAPN for highly complex renal tumors, with multivariable analysis identifying right-sided tumors (p = 0.0217), non-hilar location (p = 0.0056), shorter operative time (p < 0.0001), and an unexposed urinary system (p = 0.0022) as independent predictors of success.
- Pentafecta was achieved in 31% (104/334) of evaluable patients at 1 year, independently associated with non-hilar tumors (p = 0.0449), shorter operative time (p = 0.0003), and absence of urinary system exposure (p = 0.0004).
Read the original sourceInternational Journal of Urology
